For breast invasive carcinoma (BRCA; Fig. 7a), prostate adenocarcinoma (PRAD; Fig. 7b) and the pan-kidney cohort (KIPAN; Fig. 7c) high TEX19 expression is associated with poor prognosis; although the difference is marginal for PRAD. Here, TEX19 is linked to invasive breast carcinoma.